In previous studies, BID, FBXW7, and GPX4 had already been found to be significant in thyroid cancer [21,22,23], whereas the role of AKR1C3 and MAP3K5 in the development and progression of thyroid cancer has not yet been reported. Here, AKR1C3 is linked to thyroid gland carcinoma.